2022
DOI: 10.1016/j.ijporl.2022.111376
|View full text |Cite
|
Sign up to set email alerts
|

Hearing outcomes in children with Congenital Cytomegalovirus: A multi-center, single-enterprise experience

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 38 publications
0
2
0
Order By: Relevance
“…Worldwide literature reports cases of stabilization of local retinal conditions or resolution of choroidal and retinal inflammation after antiviral treatment with gancyclovir or valgancyclovir in infants with cCMV [ 31 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 ]. However, authors of available studies on cCMV treatment often focus on complications other than ophthalmologic ones, primarily hearing disorders and the effectiveness of antiviral treatment in treating them [ 125 , 126 , 127 , 128 , 129 , 130 , 131 ]. Consequently, further studies involving a larger number of patients and employing detailed, targeted ophthalmologic diagnostics are necessary to determine the efficacy of antiviral therapy in the treatment of cCMV.…”
Section: Discussionmentioning
confidence: 99%
“…Worldwide literature reports cases of stabilization of local retinal conditions or resolution of choroidal and retinal inflammation after antiviral treatment with gancyclovir or valgancyclovir in infants with cCMV [ 31 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 ]. However, authors of available studies on cCMV treatment often focus on complications other than ophthalmologic ones, primarily hearing disorders and the effectiveness of antiviral treatment in treating them [ 125 , 126 , 127 , 128 , 129 , 130 , 131 ]. Consequently, further studies involving a larger number of patients and employing detailed, targeted ophthalmologic diagnostics are necessary to determine the efficacy of antiviral therapy in the treatment of cCMV.…”
Section: Discussionmentioning
confidence: 99%
“…The recent neonatal guidelines recommending cCMV infection screening at birth contributed to observing shifts in the prevalence of cCMV; both centers have reached a stabilization in the annual number of cases. It is necessary to underline that in the absence of targeted or universal cCMV screening, most children are identified due to symptoms suggestive of cCMV infection [24]; in this regard, a recent position statement on the early-identification of hearing loss in cCMV infection through the NHS program has been published [25]. In recent years, the importance of newborn hearing screening in diagnosing congenital hearing loss has been demonstrated.…”
Section: Discussionmentioning
confidence: 99%
“…Currently, as there is no virological marker to predict who will develop sequelae [6], a better understanding of the natural history of the virus would be determinant in order to identify children at higher risk of developing hearing loss and to program tailored follow-up [38] through specific indicators [24]. Research has shown that the virus evolves on much shorter timescales and within individual infected subjects [39].…”
Section: Discussionmentioning
confidence: 99%